incretin hormone glp-1 axis and incretin-based therapies: is produced by the Incretin Hormones: Mechanisms, Therapeutic Implications,

The medication works by mimicking a naturally occurring hormone called GLP-1, which is released in the gut after eating

Anyone considering a GLP-1 drug should talk with both their primary care or obesity medicine doctor and their neurologist, says Ali

doi: 10.3389/fphys.2026.1796160 Received 26 January 2026 Revised 16 March 2026 Accepted 23 March 2026 Published 20 April 2026 Volume 17 - 2026 Edited by Dario A

While widely recognized for their ability to support significant and sustained weight loss, their benefits extend far beyond the number on the scale

In this article (5 sections) Ipamorelin is not an approved medicine anywhere, which means it carries no regulatory label and no official adverse-event profile [1]